CLNN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Clene Inc.

NASDAQ | CLNN

7.30

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$94.76M

Market Cap

-

P/E Ratio

-3.78

EPS

$13.50

52 Week High

$2.28

52 Week Low

CONSUMER DEFENSIVE

Sector

CLNN Chart

Recent Chart
Price Action

CLNN Technicals

Tags:

CLNN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $272K
Total Revenue $342K
Cost Of Revenue $70K
Costof Goods And Services Sold $70K
Operating Income -$33M
Selling General And Administrative $13M
Research And Development $20M
Operating Expenses $33M
Investment Income Net -
Net Interest Income -$4M
Interest Income $865K
Interest Expense $4.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$39M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$34M
Net Income -$39M

Revenue & Profitability

Earnings Performance

CLNN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $27M
Total Current Assets $16M
Cash And Cash Equivalents At Carrying Value $12M
Cash And Short Term Investments $12M
Inventory $68K
Current Net Receivables $391K
Total Non Current Assets $11M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $3.5M
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $10M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $26M
Capital Lease Obligations $5.1M
Long Term Debt $15M
Current Long Term Debt $359K
Long Term Debt Noncurrent -
Short Long Term Debt Total $21M
Other Current Liabilities $5.1M
Other Non Current Liabilities -
Total Shareholder Equity -$8.9M
Treasury Stock -
Retained Earnings -$282M
Common Stock $1K
Common Stock Shares Outstanding $7M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$21M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $15K
Change In Receivables -
Change In Inventory -$31K
Profit Loss -
Cashflow From Investment $6.3M
Cashflow From Financing -$1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$39M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $272K
Total Revenue $342K
Cost Of Revenue $70K
Costof Goods And Services Sold $70K
Operating Income -$33M
Selling General And Administrative $13M
Research And Development $20M
Operating Expenses $33M
Investment Income Net -
Net Interest Income -$4M
Interest Income $865K
Interest Expense $4.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$39M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$34M
Net Income -$39M

CLNN Profile

Clene Inc. Profile

Sector: CONSUMER DEFENSIVE

Industry: PACKAGED FOODS

Clene Inc. is an innovative clinical-stage pharmaceutical firm headquartered in Salt Lake City, Utah, specializing in the development of clean-surface nanotechnology (CSN) therapies intended to address neurodegenerative diseases and other critical health conditions. With a strong emphasis on rigorous clinical trials, Clene is focused on achieving regulatory approvals for its advanced product pipeline, which positions the company as a potential leader in transforming treatment options within the biopharmaceutical sector. Given its robust scientific foundation and strategic vision, Clene presents an attractive opportunity for institutional investors seeking growth in the healthcare market.

NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-8.15%
$7.94
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
PLTR
-3.55%
$184.17
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
BURU
-8.60%
$0.25
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
PBR
-3.63%
$12.98
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-8.15%
$7.94
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
PLTR
-3.55%
$184.17
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
BURU
-8.60%
$0.25
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
PBR
-3.63%
$12.98
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.